Unlocking Q2 Potential of PTC Therapeutics (PTCT): Exploring Wall Street Estimates for Key Metrics

Analysts on Wall Street project that PTC Therapeutics (PTCT) will announce quarterly loss of $1 per share in its forthcoming report, representing an increase of 62.4$192.12 million, declining 10.1% from the same quarter last year. The consensus EPS estimate for the quarter has undergone an upward revision of 2% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates ...